Postnatal development of organic cation transport in the rat liver

被引:26
作者
Martel, F [1 ]
Martins, MJ
Calhau, C
Hipolito-Reis, C
Azevedo, I
机构
[1] Fac Med, Inst Pharmacol & Therapeut, P-4200 Oporto, Portugal
[2] Fac Med, Dept Biochem, P-4200 Oporto, Portugal
关键词
postnatal; development; liver; transport; MPP+;
D O I
10.1006/phrs.1997.0283
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous studies have demonstrated that the small permanently charged organic cation 1-methyl-4-phenylpyridinium (MPP+) is avidly taken up by rat hepatocytes. The aim of this study was to characterise the postnatal development of hepatic uptake of organic cations, using the model compound MPP+. Accumulation of [H-3]MPP+ by liver slices obtained from rats ranging from 1 day to 7 weeks was measured, and the effect of a series of compounds on [H-3]MPP+ uptake was examined. The accumulation of [H-3]MPP+ by liver slices was similar in adult (87.5 +/- 19.9 pmol g(-1); n = 7) and neonatal rats (110.6 +/- 11.5 pmol g(-1); n = 15). Verapamil, quinidine (100 mu M) and progesterone (200 mu M) produced very marked reductions on [H-3]MPP+ uptake at all ages, and the inhibitory effect of verapamil and quinidine was maximum in livers from 1-day-old rats. Bilirubin (200 mu M) significantly reduced [H-3]MPP+ uptake by liver slices from 1 day, 1 week and 7-week-old rats. However, [H-3]MPP+ accumulation was reduced by cimetidine, vinblastine and daunomycin (100 mu M) in 1-day-old rats, but the effect of these drugs disappeared as the animals age increased. These findings demonstrate that hepatic organic cation uptake capacity is remarkably high shortly after birth and suggest that at least two distinct uptake mechanisms are involved in this process. These uptake systems are the type I hepatic transporter of organic cations, active from birth to adulthood, and P-glycoprotein, active only in very young rats. (C) 1998 The Italian Pharmacological Society.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 20 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
BUSCHMAN E, 1994, ANTICANCER DRUG RESI, P17
[3]  
DUTT A, 1992, J PHARMACOL EXP THER, V261, P1222
[4]   HEPATOBILIARY SECRETION OF ORGANIC-COMPOUNDS - MOLECULAR MECHANISMS OF MEMBRANE-TRANSPORT [J].
ELFERINK, RPJO ;
MEIJER, DKF ;
KUIPERS, F ;
JANSEN, PLM ;
GROEN, AK ;
GROOTHUIS, GMM .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1995, 1241 (02) :215-268
[5]   EXPRESSION OF A MULTIDRUG-RESISTANCE GENE IN HUMAN-TUMORS AND TISSUES [J].
FOJO, AT ;
UEDA, K ;
SLAMON, DJ ;
POPLACK, DG ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :265-269
[6]   BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER [J].
GOTTESMAN, MM ;
PASTAN, I .
ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 :385-427
[7]   DRUG EXCRETION MEDIATED BY A NEW PROTOTYPE OF POLYSPECIFIC TRANSPORTER [J].
GRUNDEMANN, D ;
GORBOULEV, V ;
GAMBARYAN, S ;
VEYHL, M ;
KOEPSELL, H .
NATURE, 1994, 372 (6506) :549-552
[8]  
KAMIMOTO Y, 1989, J BIOL CHEM, V264, P11693
[9]  
KLAASSEN CD, 1984, PHARMACOL REV, V36, P1
[10]   Inward transport of [H-3]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: Putative involvement of a P-glycoprotein transporter [J].
Martel, F ;
Martins, MJ ;
HipolitoReis, C ;
Azevedo, I .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (08) :1519-1524